US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
The process for preparing blood components is the centrifugation of one unit of the whole blood. The whole blood comprises of colloids, cells and crystalloids which can be differentiated into different blood components such as red blood cell, white blood cell, platelet, plasma, and precipitate. For therapeutic efficacy, these different blood components need different temperature requirements and storage conditions. The blood preparation market is developing due to the increasing use of leucocyte reduced RBCs, platelet concentrate, packed red cells, cryoprecipitate and the whole blood components. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Blood Preparation Report by Material, Application, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China). In this report, the global Blood Preparation market is valued at USD XX million in 2019 and is projected to reach USD XX million by the end of 2023, growing at a CAGR of XX% during the period 2019 to 2023. The report firstly introduced the Blood Preparation basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world’s main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis. The major players profiled in this report include: AstraZeneca PLC Sanofi S.A. LEO Pharma A/S Bristol-Myers Squibb Company Baxter International, Inc. Pfizer, Inc. Portola Pharmaceuticals, Inc. GlaxoSmithKline PLC The end users/applications and product categories analysis: On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into- Platelet Aggregation Inhibitors Fibrinolytics Anticoagulants On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Blood Preparation for each application, including- Thrombocytosis Pulmonary Embolism Renal Impairment Angina Blood Vessel Complications
Table of Contents Part I Blood Preparation Industry Overview Chapter One Blood Preparation Industry Overview 1.1 Blood Preparation Definition 1.2 Blood Preparation Classification Analysis 1.2.1 Blood Preparation Main Classification Analysis 1.2.2 Blood Preparation Main Classification Share Analysis 1.3 Blood Preparation Application Analysis 1.3.1 Blood Preparation Main Application Analysis 1.3.2 Blood Preparation Main Application Share Analysis 1.4 Blood Preparation Industry Chain Structure An | read more...